Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (83)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ginovart, N.
Right arrow Articles by Sedvall, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ginovart, N.
Right arrow Articles by Sedvall, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol 120, Issue 3 503-514, Copyright © 1997 by Oxford University Press

ARTICLES

PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease

N Ginovart, A Lundin, L Farde, C Halldin, L Backman, CG Swahn, S Pauli and G Sedvall
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

PET and: markers for the pre- and postsynaptic neurons were used to study the dopamine system in vivo in Huntington's disease. The radioligands used were [11C]SCH 23390 for D1-receptors, [11C]raclopride for D2-receptors and [11C]beta-CIT for dopamine transporters. Five patients with Huntington's disease and five matched controls were recruited. Brain anatomy was examined by MRI. The findings in patients were as follows. Postsynaptic D1- and D2-receptor densities were similarly reduced in the striatum. A reduction in D1-receptor density was shown in the temporal cortex; it draws attention to the cortical degeneration in relation to the cognitive deficits observed in Huntington's disease. The reduction of D1- and D2-receptor binding potentials in the striatum correlated significantly with increasing duration of illness. The correlation between the duration of illness and decline of D1- and D2-receptors make these receptors valuable as quantitative markers for the Huntington's disease degenerative process. Besides postsynaptic changes, a significant 50% decrease of [11C]beta- CIT binding to the dopamine transporter was found in the striatum. A reduced striatal blood flow in Huntington's disease cannot be excluded and could account for a small part of the decrease in [11C]beta-CIT binding. We suggest that the finding reflects a loss of presynaptic terminals or a reduced expression of dopamine transporter in the nigrostriatal dopaminergic system in Huntington's disease.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BrainHome page
M. Politis, N. Pavese, Y. F. Tai, S. J. Tabrizi, R. A. Barker, and P. Piccini
Hypothalamic involvement in Huntington's disease: an in vivo PET study
Brain, November 1, 2008; 131(11): 2860 - 2869.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Y. Heng, S. J. Tallaksen-Greene, P. J. Detloff, and R. L. Albin
Longitudinal Evaluation of the Hdh(CAG)150 Knock-In Murine Model of Huntington's Disease
J. Neurosci., August 22, 2007; 27(34): 8989 - 8998.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
T.-S. Tang, X. Chen, J. Liu, and I. Bezprozvanny
Dopaminergic Signaling and Striatal Neurodegeneration in Huntington's Disease
J. Neurosci., July 25, 2007; 27(30): 7899 - 7910.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
N. Pavese, A. Gerhard, Y. F. Tai, A. K. Ho, F. Turkheimer, R. A. Barker, D. J. Brooks, and P. Piccini
Microglial activation correlates with severity in Huntington disease: A clinical and PET study
Neurology, June 13, 2006; 66(11): 1638 - 1643.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
W.-D. Heiss and K. Herholz
Brain Receptor Imaging
J. Nucl. Med., February 1, 2006; 47(2): 302 - 312.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
H. D. Rosas, W. J. Koroshetz, Y. I. Chen, C. Skeuse, M. Vangel, M. E. Cudkowicz, K. Caplan, K. Marek, L. J. Seidman, N. Makris, et al.
Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis
Neurology, May 27, 2003; 60(10): 1615 - 1620.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
A. D. Lawrence, L. H. A. Watkins, B. J. Sahakian, J. R. Hodges, and T. W. Robbins
Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits
Brain, July 1, 2000; 123(7): 1349 - 1364.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
N. I. Bohnen, R. A. Koeppe, P. Meyer, E. Ficaro, K. Wernette, M. R. Kilbourn, D. E. Kuhl, K. A. Frey, and R. L. Albin
Decreased striatal monoaminergic terminals in Huntington disease
Neurology, May 9, 2000; 54(9): 1753 - 1759.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
T. C. Andrews, R. A. Weeks, N. Turjanski, R. N. Gunn, L. H. A. Watkins, B. Sahakian, J. R. Hodges, A. E. Rosser, N. W. Wood, and D. J. Brooks
Huntington's disease progression: PET and clinical observations
Brain, December 1, 1999; 122(12): 2353 - 2363.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. Drago, P. Padungchaichot, J. Y. F. Wong, A. J. Lawrence, J. F. McManus, S. H. Sumarsono, A. L. Natoli, M. Lakso, N. Wreford, H. Westphal, et al.
Targeted Expression of a Toxin Gene to D1 Dopamine Receptor Neurons by Cre-Mediated Site-Specific Recombination
J. Neurosci., December 1, 1998; 18(23): 9845 - 9857.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
D. S. Reynolds, R. J. Carter, and A. J. Morton
Dopamine Modulates the Susceptibility of Striatal Neurons to 3-Nitropropionic Acid in the Rat Model of Huntington's Disease
J. Neurosci., December 1, 1998; 18(23): 10116 - 10127.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.